The human steroid sulfatase gene (STS) is located on the distal X chromosome short arm close to the pseudoautosomal region but in a segment ofDNA that is unique to the X chromosome. In contrast to most X chromosomeencoded genes, STS expression is not extinguished during the process of X chromosome inactivation. Deficiency of STS (steryl-sulfatase; steryl-sulfate sulfohydrolase, EC 3.1.6.2) activity produces the syndrome of X chromosome-linked ichthyosis, which is one of the most common inborn errors of metabolism in man. Approximately 90% of STS-individuals have large deletions at the STS locus. We and others have found that the end points of such deletions are heterogeneous in their location. One recently ascertained subject was observed to have a 40-kilobase deletion that is entirely intragenic, permitting the cloning and sequencing of the deletion junction. Studies of this patient and of other X chromosome sequences in other subjects permit some insight into the mechanism(s) responsible for generating frequent deletions on the short arm of the X chromosome.
ABSTRACT
The human steroid sulfatase gene (STS) is located on the distal X chromosome short arm close to the pseudoautosomal region but in a segment ofDNA that is unique to the X chromosome. In contrast to most X chromosomeencoded genes, STS expression is not extinguished during the process of X chromosome inactivation. Deficiency of STS (steryl-sulfatase; steryl-sulfate sulfohydrolase, EC 3.1.6.2) activity produces the syndrome of X chromosome-linked ichthyosis, which is one of the most common inborn errors of metabolism in man. Approximately 90% of STS-individuals have large deletions at the STS locus. We and others have found that the end points of such deletions are heterogeneous in their location. One recently ascertained subject was observed to have a 40-kilobase deletion that is entirely intragenic, permitting the cloning and sequencing of the deletion junction. Studies of this patient and of other X chromosome sequences in other subjects permit some insight into the mechanism(s) responsible for generating frequent deletions on the short arm of the X chromosome.
Steroid sulfatase (STS; steryl-sulfatase; steryl-sulfate sulfohydrolase, EC 3.1.6.2) deficiency is one of the most prevalent human inborn errors of metabolism. Several studies have estimated the frequency of this condition at between 1/6000 and 1/2000 males (1) . In addition, a phenotypic indicator of STS deficiency, X chromosome-linked ichthyosis (XLI), has been recognized with a similar incidence in virtually every social and ethnic group. STS is a microsomal enzyme, expressed in essentially all tissues, that hydrolyzes various 30-hydroxysteroid sulfates. The gene that encodes the 62-kDa polypeptide has been cloned and characterized. It contains 10 exons, spread over 146 kilobases (kb) of DNA on the distal short arm of the X chromosome, close to the boundary of the X unique and pseudoautosomal regions (2) .
STS deficiency during fetal life results in impaired maternal-fetal estrogen production due to lack of STS activity in the placenta. This endocrinologic situation is sometimes associated with delayed progression of parturition. The clinical abnormalities seen postnatally in STS-deficient patients are usually restricted to abnormal levels of circulating steroid sulfates and ichthyosis. However, some patients have more complex phenotypes, which can include short stature with stippled epiphyses (the Conradi syndrome), hypogonadotropic hypogonadism with anosmia (the Kallmann syndrome), mental retardation, ocular albinism, and neurologic abnormalities. Such individuals are thought to have extensive deletions of their X chromosomes, which could produce contiguous gene loss. In support of this concept, =90% of patients with simple deficiency of STS and isolated ichthyosis appear to have molecular evidence of deletion of some or all of their STS gene sequences (3) (4) (5) (6) (7) .
In an effort to understand the basis for the very frequent deletions seen in STS-deficient subjects, we have undertaken a molecular analysis of a number of these patients to attempt to define the heterogeneity of breakpoints in these deletions. We wished to identify any potential sequences that might be prone to undergo either intra-or interchromosomal nonhomologous recombination. Most of the breakpoints occur at a substantial distance from the STS gene itself and so far have been difficult to characterize. However, we have found one subject who has an entirely intragenic deletion of a portion of his STS locus. Thus, the end points of this deletion can be defined with existing molecular reagents and are amenable to direct analysis.
MATERIALS AND METHODS
Patients, Cell Lines, and Probes. All patients, except nos. 29 and 30, had typical XLI without other phenotypic abnormalities. They derived from a variety of clinical sources and geographic regions and were originally referred to our laboratory for diagnostic purposes. All patient materials were cultured fibroblast cell lines, except nos. 3, 9, 10, 11, 12, in which somatic cell hybrid lines containing the patient's X chromosome had been constructed on a mouse A9 background. Patient 29 had neurologic abnormalities and the Kallmann syndrome in addition to XLI; he was karyotypically normal. He was previously reported by Sunohara et al. (8) . Patient 30 had a visible deletion of the distal X chromosome short arm and was described by Curry et al. (9) . Patient J.H. had isolated XLI that was indistinguishable from that seen in other subjects. Probe dic56 (DXS143) was kindly provided by Louis Kunkel (Boston), 38j (DXS283) was donated by Jean Weissenbach (Paris), and GMGX9 (DXS237) was given by Malcolm Ferguson-Smith (Cambridge).
Isolation of DNA and RNA. High molecular weight DNA was isolated from human leukocytes, fibroblasts, or mousehuman hybrid cells containing a human X chromosome by proteinase K treatment and phenol extraction as described (10) . Poly(A)+ RNA was isolated from human placenta or tissue culture cells by guanidinium SCN-CsCl gradient and oligo(dT)-cellulose chromatography (11) .
Restriction Digestion and Hybridization Analysis of DNA and RNA. Conditions for restriction digestion and Southern blotting of cellular DNA have been described (4 §To whom reprint requests should be addressed.
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precipitation buffer (10 mM Tris/150 mM NaCl/1% Nonidet P-40, pH 7.5) at 40C and harvested. The lysate was precleared with goat anti-human fibronectin serum and then with normal rabbit serum. STS protein was then immunoprecipitated at 40C overnight with rabbit antiserum against human STS protein purified by affinity chromatography (4). Immunoprecipitates were resolved on a 7.5% SDS/PAGE gel followed by fluorography.
Library Construction and Screening. About 100 Ag of J.H.
hybrid DNA was digested to completion with BamHI and size fractionated on a sucrose gradient. The fragments of -18 kb in length were ligated to AEMBL3 arms and packaged in vitro using a Gigapack Gold kit from Stratagene. About 1 x 106 recombinant phages from the library were plated and screened according to the plaque-hybridization procedure of Benton and Davis (13) . Subcloning and DNA Sequencing. Appropriate EcoRI fragments from the A clones were subcloned in pUC19 for more detailed restriction mapping. DNA sequences of the junction fragment and the corresponding regions from a normal individual were determined by the dideoxy chain-termination method (14) using either the Klenow fragment of Escherichia coli DNA polymerase I or Sequenase (United States Biochemical).
RESULTS
Characterization of the Molecular Defects in STS-Deficient Patients. We have studied the molecular defects in 30 unrelated STS-deficient patients (Table 1) , including 10 used in our previous study (4) . Patients 1-28 have ichthyosis as their only phenotypic abnormality. Patient 29 has the Kallmann syndrome and neurological abnormalities in addition to ichthyosis. Patient 30 (D.R.) has a cytologically visible deletion of the tip of the short arm of his X chromosome. All patients were shown to have undetectable levels of STS enzyme activity.
We have evaluated the defects in these patients in three ways: the STS gene structure, the presence of STS-encoded mRNA, and the presence of inactive proteins or protein fragments detectable with anti-STS antiserum. For STS gene structure studies, DNAs were isolated from the patients, digested with EcoRI, and probed with a human STS cDNA pSTS331 ( Fig. 1 ). Normal males gave 10 hybridization bands. The sizes of the fragments have been modified from those given in a previous communication (4) . The 17-kb and the 1.4-kb fragments detected by pSTS331 contain pseudogene sequences on the Y chromosome, whereas the rest of the fragments correspond to the functional STS gene sequences on the X chromosome. Comparison of the Southern hybridization patterns of the patients to that of normal individuals should reveal any gross rearrangements in gene structure.
For mRNA studies, poly(A)+ RNA was isolated from cultured fibroblasts of the patients or from mouse-human hybrid cells containing patients' X chromosomes as in the case of J.H. The RNAs were separated on gels, transferred to nitrocellulose membranes, and probed with pSTS331 ( Fig.  2) . Three major species of STS mRNA (7.2 kb, 5.2 kb, and 2.7 kb) have been identified in various human tissues. This variation is produced by alternative sites of poly(A) addition. Normal fibroblasts and mouse-human hybrids with normal human X chromosomes contain mainly the 7.2-kb and the 5.2-kb mRNA forms.
For protein studies, normal or patients' fibroblasts were grown in the presence of [3H]leucine, and the cell extracts were treated with anti-STS antiserum. The immunoprecipitated fractions were then analyzed on SDS/PAGE gels (Fig.  3) . As positive controls, a female fibroblast cell line, IMR90, and A9(hSTS) cells were used. A9(hSTS) are mouse A9 cells transfected with a human STS expression vector pMSG: STS331 and thus express high level of STS enzymatic activity (Fig. 2) . Immunoprecipitation of T.A. and C cell extracts failed to detect any protein that binds specifically to anti-STS antiserum (Fig. 3) . It (Fig. 3) .
Characterization AATAATAG, which is 8 bp 5' of the breakpoint. p126SRB and p116B contain only single-copy sequences. Computer searches could not identify any significant homology between the 5' and the 3' flanking regions of the deletion, nor could any extensive predicted secondary structures be found.
DISCUSSION
Several groups have studied the molecular defects in STSdeficient patients using either human STS cDNA clones (3-7) or probe GMGX9, an anonymous DNA fragment tightly linked to the STS locus (16). All found a high incidence of deletions. A total of 102 STS-deficient patients has been studied collectively and only 13 patients' DNA contains all or part of the STS X chromosome-encoded sequences. The results in 57 of these patients were inconclusive because their DNAs were studied with incomplete cDNA fragments (3, 5, 7) , which would score a partial deletion either positive or negative depending on the sizes and locations of the deletions. In the two studies using nearly full-length cDNA (refs. 4, 6 and present studies), 41 of 45 patients (91%) have complete deletions of the STS-X locus. This renders STS deficiency the human genetic defect with the highest incidence of complete gene deletion so far reported (17) . We and others have suggested that this high incidence of deletions might be caused by aberrant X-Y interchange. In fact, several lines of evidence now argue against such events. All of the deletion patients we have studied retain sequences detected by 38j (18) , an X chromosome-specific marker distal to STS which would have been lost if the deletion was caused by X-Y interchange. Furthermore, using a number of distal Yp probes, we were unable to detect any Y sequences on the X chromosomes of four STS patients (unpublished observation). Finally, in a recent study of seven XX males, we found that all of them retain the STS-X locus on their X chromosomes, which have acquired Y DNA sequences through a documented X-Y interchange process.
The magnitude of the deletion at the STS-X locus is not known. There appears to be heterogeneity among patients. Cooke et al. (19) were able to detect the deletions in some but not all STS-deficient patients using flow cytometry. They suggested deletions ranging from 1.2% to 3.4% of the length of the X chromosome (equivalent to 1. (7) reported a patient with a deletion of the 3' end of the gene. We describe here a patient with a 45-kb intragenic deletion. The molecular mechanisms that generate deletions are not known. Some deletions appear to be produced by recombination between homologous sequences. Deletions generated by unequal crossing-over between homologous chromosomes have been defined in the human globin gene clusters (21) and the growth hormone cluster (22) . Other deletions seem to involve recombination between repetitive sequences, often Alu sequences, as in the case of low density lipoprotein (LDL) receptor gene (23) (24) (25) and a-globin gene cluster (26) . There are also others that do not seem to involve any repetitive sequences (27, 28) . It has been suggested that such deletions can be caused by nonhomologous DNA exchanges between stretches of DNAs that were in the proximity of each other through their attachment to some kind of cellular structure, possibly scaffolding proteins. In Drosophila scaffolding-associated DNA fragments were found to contain sequences homologous to topoisomerase II cleavage sites (29) . The deletion in J.H. fell in regions containing only single-copy sequence. There is no obvious secondary structure around the breakpoints that could facilitate the recombination. It is noted that the sequence (GTG-GAGATTAATACA) that matches 13/15 of the consensus sequences of the topoisomerase II cleavage site [GTNA/ TATCATTNATNNG/A (30)] is present 18 bp 3' of the breakpoint. An 8-bp repeat was generated during the creation of this deletion. A similar situation was found in a deletion in a LDL receptor gene where an 11-bp sequence was duplicated at the deletion junction (24) .
Although X-Y interchange does not appear to be a likely mechanism for producing STS deletions, unequal X-X recombination in female germ cells cannot be excluded nor can intrachromosomal recombinations and/or sister chromatid exchanges during male or female meiosis. Finally, gene loss during mitotic division of spermatogenia or oogonia is a possibility. It is of note that at least 70% of patients with Duchenne muscular dystrophy have sustained deletions of their dystrophin genes, which are also situated on the X chromosome short arm (31) . From the evidence presented here and elsewhere, it is clear that there is some heterogeneity in the position of breakpoints in STS deletions. Further studies to determine the precise location and sequences of such deletion junctions will be required to determine the precise molecular mechanisms that produce these frequent rearrangements. 
